August 8, 2025 - 02:14

Skywater Technology is optimistic that delays in federal funding will be short-lived as it embarks on a significant acquisition aimed at enhancing its operational capacity. The company has announced its first major acquisition, which is expected to bolster its capabilities and position in the semiconductor industry. This strategic move comes at a time when Skywater is navigating the complexities of government funding, which has faced unexpected setbacks.
Despite these challenges, Skywater remains confident in its long-term growth prospects. The acquisition not only signifies a commitment to expanding its technological infrastructure but also reflects the company’s belief in the eventual resolution of funding issues. By increasing its capacity, Skywater aims to better serve its clients and meet the growing demands of the market.
As the semiconductor landscape continues to evolve, Skywater Technology's proactive approach could position it favorably for future opportunities, reinforcing its status as a key player in the industry.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...